Identity
What is Sermorelin?
GHRH(1-29)-NH2; the acetate salt needs its own documentation.

Research reference · Hormones
Sermorelin is a synthetic 29-residue analog of the active end of growth-hormone-releasing hormone, GHRH(1-29). It was previously marketed in the U.S. as Geref.
Published by Elevated Pharma ·
Identity
GHRH(1-29)-NH2; the acetate salt needs its own documentation.
Research context
Human endocrine studies used GHRH(1-29) to test pituitary growth-hormone response; recent literature focuses on detection methods and sports use.
Evidence boundary
A base-compound record does not establish acetate content, purity or potency of a specific material.
U.S. status · November 7, 2026
No current FDA-approved sermorelin product is marketed. It was not on FDA’s 2026 compounding advisory agendas.
Key studies
Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.
Search all 199 PubMed records for Sermorelin · Counts and selections checked November 7, 2026.
Reference identifiers
Database identity describes the reference substance, not any specific material or lot.
Official & primary sources
Citation does not imply an Elevated Pharma partnership or endorsement.